Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin in Prevention of Lupus Nephritis in High Risk SLE Patients
NCT04145687Phase 4Unknown
- Sponsor
- Renji Hospital
- Start
- Nov 2019
- Primary completion
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in lupus nephritis (LN) comparing Metformin with Placebo (2 arms). Primary endpoint: Prevention of new-onset Lupus Nephritis at 12 months. Status: unknown.
02
Drugs
metformin
03
Conditions
lupus nephritis (LN)
Beyond the preview
Go deeper on NCT04145687.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04145687.